Stocks / BDX
BDX stock
BECTON DICKINSON & CO · Healthcare · Medical Instruments & Supplies
Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.
BDX is not among the 20 largest holdings published for 2026 Q4. See the portfolio
BDX against the S&P 500
| Period | BDX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +13.3% | -4.7% |
| 3 months | +15.9% | -4.8% |
| Year to date | +42.8% | +7.9% |
| 1 year | +44.9% | +11.8% |
Total return, dividends included.
Key numbers
| Price | $216.08 |
| Market cap | 58.86 Billion |
| P/E (trailing 12 months) | 65.1 |
| P/S (trailing 12 months) | 2.8 |
| P/B (latest quarter) | 2.0 |
| Gross margin | 46.4% |
| Net profit margin | 4.5% |
| Return on equity | 3.8% |
| Beta | 0.3 |
As of August 6, 2026.
BDX and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| RMD | RESMED INC | 34.12 Billion | Outperform | BDX vs RMD |
| WST | WEST PHARMACEUTICAL SERVICES INC | 28.14 Billion | Greatly Underperform | BDX vs WST |
| BAX | BAXTER INTERNATIONAL INC | 13.53 Billion | Greatly Outperform | BDX vs BAX |
| COO | COOPER COMPANIES INC | 11.55 Billion | Underperform | |
| ISRG | INTUITIVE SURGICAL INC | 145.92 Billion | Outperform | ISRG vs BDX |
Questions
How is the BDX rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is BDX in the Upfront Investment model portfolio?
BDX is not among the 20 largest holdings published for 2026 Q4.
The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.